SIRT5 promotes non-small cell lung cancer progression by reducing FABP4 acetylation level

Zhen Li(The First Hospital of Changsha), Hui Chen(Fujian Medical University)
Neoplasma
January 1, 2022
Cited by 16


Related Papers